Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

# HCC

Home » # HCC
Combination locoregional therapy with systemic therapy for intermediate and advanced stage HCC

Combination locoregional therapy with systemic therapy for intermediate and advanced stage HCC

Posted by By Xiaorong JI 2024.02.19
<Hepatology Digest>: How does the combination locoregional therapy with systemic therapy improve the prognosis and survival rates for patients with intermediate and advanced stage HCC, and what are the synergistic effects…
Read More
The main mechanisms and strategies of HCC combination therapy

The main mechanisms and strategies of HCC combination therapy

Posted by By Xiaorong JI 2024.02.19
<Hepatology Digest>: What is the specific efficacy of combination therapies in improving tumor response in HCC, and how can the optimal treatment combinations and timing be determined?
Read More
Current treatment status and challenges for intermediate and advanced stage HCC

Current treatment status and challenges for intermediate and advanced stage HCC

Posted by By Xiaorong JI 2024.02.18
<Hepatology Digest>: What is the efficacy of current treatment strategies for intermediate and advanced stage HCC, and what are the challenges and limitations associated with them?
Read More
The mechanism of tumor microenvironment affecting the occurrence and development of HCC

The mechanism of tumor microenvironment affecting the occurrence and development of HCC

Posted by By Xiaorong JI 2024.02.18
<Hepatology Digest>: How does the tumor immune microenvironment affect the efficacy of precision HCC therapy?
Read More
Progress in the Treatment of Intermediate and Advanced HCC, Highlighting the Value of Systemic Therapy

Progress in the Treatment of Intermediate and Advanced HCC, Highlighting the Value of Systemic Therapy

Posted by By Xiaorong JI 2024.01.31
Read More
The main mechanisms and development prospects of HCC combination therapy

The main mechanisms and development prospects of HCC combination therapy

Posted by By Xiaorong JI 2024.01.31
Read More
Recent Posts
  • Professor Yige Bao: From “New Leaves Spur the Old” to “One Mountain Opens, Another Blocks the Way” —Reflections and Challenges in Post-Neoadjuvant Management of MIBC
  • ESMO Hot Topic Focus | Professor Richard S. Finn: Immunotherapy-Based Combinations Turn “Stone into Gold” — The TALENTOP Study Reshapes the Treatment Landscape of Advanced HCC
  • ESMO International Perspective | Professor Maria Reig: Large International Multicenter Evidence Supports the Inclusion of EBRT in the BCLC Staging and Treatment Algorithm
  • ESMO International Perspective | 42-Month Long-Term Follow-Up with Median OS of 22.8 Months: Professor Manon Allaire Interprets the Outstanding Real-World Performance of the “T+A” Regimen
  • ESMO International Perspective | Global Lung Cancer Experts Discuss the OptiTROP-Lung04 Study: Sacituzumab Tirumotecan Breaks Through Post-TKI Resistance
Recent Comments
    Archives
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top